JP Morgan Knock-Out RNL/ DE000JQ9RXL4 /
03/06/2024 11:47:20 | Var.+0.11 | Denaro14:03:01 | Lettera14:03:01 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.50EUR | +4.60% | 2.50 Quantità in denaro: 100,000 |
2.51 Quantità in lettera: 100,000 |
RENAULT INH. EO... | 29.7346 - | 31/12/2078 | Call |
GlobeNewswire
14:20
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
GlobeNewswire
14:15
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-I...
GlobeNewswire
14:14
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire
14:10
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution ...
GlobeNewswire
14:07
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental W...
GlobeNewswire
14:05
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at...
GlobeNewswire
14:04
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
GlobeNewswire
14:01
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
GlobeNewswire
14:00
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Tre...
GlobeNewswire
14:00
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
GlobeNewswire
14:00
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome T...